Skip to content

Nakamoto, Inc. NAKA Payments for Repurchase of Common Stock

Payments for Repurchase of Common Stock at other companies

Avanos Medical logo
Avanos MedicalAVNS
$1.3M-40.9%
TeraWulf logo
TeraWulfWULF

Other financials

Income statement

See full
Revenue$1.6M+177%
Operating income-$126.2M-12,008%
Net income-$238.8M-22,903%
EPS (diluted)-$0.38-124%

Balance sheet

See full
Cash & equivalents$35.3M+2,994%
Total debt$496.0K-37.6%
Total equity$367.1M+23,907%
Total assets$620.8M+24,115%

Cash flow

See full
Operating cash flow-$23.3M-2,592%
CapEx$2.0
Free cash flow-$901.5K-332%

Valuation

See full
Market cap$68.74M-38.2%
P/S24.1×-25.5×

Profitability

See full
Operating margin-11,313%-11,486pp
Net margin-4,568.7%-4,676pp
FCF margin-113.5%-131pp

Returns & leverage

See full
Return on equity-37.6%
Debt / equity-0.3×
Current ratio0.3×-2.0×

Where this comes from

Reported directly by Nakamoto, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Nakamoto, Inc. ’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nakamoto, Inc. 's payments for repurchase of common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nakamoto, Inc. 's payments for repurchase of common stock?
Nakamoto, Inc. (NAKA) reported payments for repurchase of common stock of $561K in Q1 2026.
How has Nakamoto, Inc. 's payments for repurchase of common stock changed year-over-year?
Nakamoto, Inc. 's payments for repurchase of common stock increased by 5510.0% year-over-year, from $10K to $561K.